TIGIT and neoplasm: Studies in tumor-bearing Tigit+/+ and Tigit−/− mice demonstrated increased TIGIT expression on tumor infiltrating lymphocytes and lack of TIGIT in Tregs to be critical for immune suppression in tumor microenvironment [29,68].